Kaifeng Jin

发表

Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture

Xudong He, Heng Zhang, Jiejie Xu, 2020, Oncoimmunology.

NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

Y. Zhu, Le Xu, Jiejie Xu, 2022, Journal for ImmunoTherapy of Cancer.

Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer

Le Xu, Yuan Chang, Baoying Hu, 2021, Cancer Immunology, Immunotherapy.

Lymphocyte‐activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein‐Barr virus‐positive and MLH1‐defective gastric cancer patients

Xudong He, Heng Zhang, Jiejie Xu, 2020, International journal of cancer.

Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients

Y. Zhu, Le Xu, Weijuan Zhang, 2022, British Journal of Cancer.

Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients

Xudong He, Heng Zhang, J. Qin, 2020, Oncoimmunology.

Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

Le Xu, Jiejie Xu, Hongyi Zhang, 2022, Cancer Immunology, Immunotherapy.

B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer.

Le Xu, Jiejie Xu, Yu Zhu, 2022, European journal of cancer.

Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.

Le Xu, Yuan Chang, Baoying Hu, 2022, Urologic oncology.

SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer.

Wei Wu, Tianjiao Li, Hua-Xiang Xu, 2022, Cancer letters.

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Le Xu, Yuan Chang, Jiejie Xu, 2021, Journal for ImmunoTherapy of Cancer.

Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis

Le Xu, Yuan Chang, Jiejie Xu, 2021, Cancer Immunology, Immunotherapy.

Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients

Hongyu Zhang, Xudong He, Heng Zhang, 2020, Annals of surgery.

CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration

Xudong He, Heng Zhang, J. Qin, 2021, Cancer Immunology, Immunotherapy.

Clinical efficacy of the combined use of levofloxacin and different courses of isoniazid and rifampicin in the treatment of mild spinal tuberculosis

Zhe Zhang, X. Chen, Huiying Zhao, 2022, Tropical Journal of Pharmaceutical Research.

Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer

Y. Zhu, Le Xu, Jiejie Xu, 2022, Journal for ImmunoTherapy of Cancer.

TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer

Le Xu, Jiejie Xu, Li Liu, 2022, British Journal of Cancer.

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients

Heng Zhang, Jiejie Xu, Yun Gu, 2021, Oncoimmunology.

Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients

Le Xu, Jiejie Xu, Shengming Jin, 2022, Annals of Surgical Oncology.

Poor clinical outcomes and immunoevasive contexture in SIRPα+ tumor-associated macrophages enriched muscle-invasive bladder cancer patients.

Le Xu, Yuan Chang, Jiejie Xu, 2021, Urologic oncology.

CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer

Y. Zhu, Le Xu, Jiejie Xu, 2022, British Journal of Cancer.

Robust estimation of bacterial cell count from optical density

Farren J. Isaacs, Marjolein E. Crooijmans, Dong Ju Kim, 2020, Communications Biology.

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

Heng Zhang, Yifan Cao, H. Fang, 2020, Oncoimmunology.

Integrating angiogenesis signature and tumor mutation burden for improved patient stratification in immune checkpoint blockade therapy for muscle-invasive bladder cancer.

Y. Zhu, Le Xu, Jiejie Xu, 2023, Urologic oncology.

Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome geneKDM6Amutation

Le Xu, Jiejie Xu, Yu Zhu, 2023, BMJ Oncology.

Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer

Le Xu, Jiejie Xu, Yu Zhu, 2024, British journal of cancer.

RAD51 Expression as a Biomarker to Predict Efficacy of Platinum-Based Chemotherapy and PD-L1 Blockade for Muscle-Invasive Bladder Cancer.

Yu Zhu, Weijuan Zhang, Zewei Wang, 2024, Journal of immunotherapy.

Integration of CD4+ T cells and molecular subtype predicts benefit from PD‐L1 blockade in muscle‐invasive bladder cancer

Le Xu, Yu Zhu, Weijuan Zhang, 2024, Cancer science.

TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma

Le Xu, Jiejie Xu, Yu Zhu, 2024, The Journal of pathology.

POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1

Le Xu, Jiejie Xu, Yu Zhu, 2024, Cancer medicine.

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

Y. Zhu, Weijuan Zhang, Zewei Wang, 2023, BMC Cancer.